Australia's most trusted
source of pharma news
Tuesday, 16 December 2025
Tuesday, 16 December 2025
Subscribe
Login
Pharmas on Santa's Naughty List
These pharmas have racked up billions of dollars in corporate fines, penalties and settlements earning a place on America's Most Penalised Companies List.
TGA tick for Aussie groundbreaker
Another stride forward toward commercialisation for this Aussie product which has the potential to revolutionise vaccine delivery
TODAY
Leaders unveil 2026 Wish List
With 2026 shaping up as a make-or-break year for Australian pharma, the country's industry leaders have high hopes
TODAY
Aussie company names new leader
Fast-growing organisation in a booming but controversial space appoints its first CEO with an internal promotion
15 December
Leaders reveal Summer plans
There's no doubt it's time for a break and ANZ Country Leaders have revealed what they'll be doing over Summer to rest and reset
15 December
No 1 for customer experience
HCPs are becoming more dissatisfied with the service provided by pharmas, but some companies are bucking the trend
12 December
Year ends with high-profile exits
Three senior staffers have announced their departure as 2025 draws to a close while others are taking fresh roles ahead of 2026
12 December
Latest Jobs
Clinical Account ManagerCommercial LeadSenior Brand ManagerSenior AccountantSite Medical DirectorBusiness Analyst / Product Owner – Digital Health (EMR)4PL Logistics LeadResearch Governance Officer22 more...
Pharma in Focus Jobs
Marketing & Communications (3)
- Senior Brand Manager - Sydney
- Business Analyst / Product Owner – Digital Health (EMR) - Melbourne
- Senior Product Manager - Sydney
Sales & Customer Relations (11)
- Clinical Account Manager - Surry Hills
- Senior Accountant - Pymble
- Medical Representative - Sunshine Coast
- Specialist Account Manager - Sydney
- Key Account Manager - Sydney
- Devices Territory Manager - Brisbane
- Clinical Research, Business Development Manager - China - Shanghai, China
- Medical Sales Representative - Wollongong
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Customer Service Representative - East Brisbane
- Head of Sales - Melbourne, VIC
Clinical & Medical, R&D (10)
- Clinical Account Manager - Surry Hills
- Site Medical Director - Sydney
- Research Governance Officer - Camberwell
- Medical Representative - Sunshine Coast
- Medical information and governance associate - Sydney
- Medical Manager - Sydney
- Clinical Research, Business Development Manager - China - Shanghai, China
- Medical Sales Representative - Wollongong
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Senior Portfolio Director - Clinical Research, China - Shanghai, China
Regulatory, Pharmacovigilance & QA (1)
Devices (1)
Executive Roles (4)
- Site Medical Director - Sydney
- Compliance & Legal Director - Macquarie Park
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Senior Portfolio Director - Clinical Research, China - Shanghai, China
Other (10)
- Commercial Lead - Melbourne
- 4PL Logistics Lead - North Sydney
- Senior Recruitment Consultant - Sydney
- Finance & Admin Officer - Macquarie Park
- Service Administrator - Belrose
- Freight & Distribution Specialist - Macquarie Park
- Warehouse Assistant - Rydalmere
- Technical Service & Warehouse Coordinator - Alexandria
- Finance Business Partner - Surry Hills
- Senior Payroll Officer - Melbourne
Who's MA's newest member?
Big Pharma joins its second industry association this year, becoming a Class One member of Medicines Australia
TODAY
New form slashes treatment time
First subcutaneous PD-1 inhibitor has been approved in Australia, offering more convenient treatment options for patients
TODAY
Inaugural pharma Summit for 2026
Senior leaders from government, industry and patient advocacy will meet next February to end the era of medicines shortages
15 December
Most powerful obesity drug yet?
Lilly unveils another winner with its triple agonist relatrutide on track to become the most effective weight loss treatment on the market
15 December
Market disruptor approved by TGA
New form of an old drug registered on the ARTG could completely change the way people use it, and it's already on PBAC's agenda
15 December Approvals Action
Butler hints at obesity drug funding
The Health Minister says there is scope in the PBS to subsidise weight loss drugs, adding the decision is not too far away
12 December
Global cost-cuts hit Aussie jobs
ICYMI: The unrelenting downsizing of the industry in ANZ continues plus the other most popular stories this week
12 December Your Week in 5 Minutes
AI analysis rescues trial efficacy
Aussie stroke drug with 'no efficacy' now shows 'significant efficacy' after AI was used to reanalyse trial info poorly judged by humans
12 December
Pharma mood 'deeply pessimistic'
After a tough few years in pharma, the industry is overwhelmingly negative but maybe there's nowhere to go but up
11 December
Big bash marks BMS milestone
Who's Who of industry, politics and patient advocacy attended an event in Melbourne last night to celebrate 70 years in Australia
11 December
$672M sale saga ends... maybe
While there's an official end to the gripping drama surrounding the failed sale of Aussie Mayne Pharma... the saga could roll on
11 December
Judge protects $74M J&J market
Generics company will need to clear the way before launching PBAC-recommended drug on the PBS
11 December
Pfizer unveils new obesity play
Hot on the heels of last month's drama-filled obesity buy, Pfizer has made another deal, this time for an oral GLP-1
11 December
Unprecedented pharma burnout
Smaller teams, heavy workloads and gruelling work hours are leaving almost no time for wellbeing, leading to burnout
10 December